SCHEMBL5729939

SCHEMBL5729939

O=C1c2ccccc2C(=O)N1CCCCN1CCC(=C2c3ccccc3CSc3sccc32)CC1

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DRD3 P35462 4/20 0.69
DRD2 P14416 2/20 0.69
LMNA P02545 2/20 0.52
JAK2 O60674 1/20 0.52
HTT P42858 1/20 0.52
HTR1A P08908 5/20 0.51
HTR7 P34969 1/20 0.51
HTR2A P28223 2/20 0.48
MAOB P27338 4/20 0.46
CYP1A2 P05177 1/20 0.44
CHRM2 P08172 1/20 0.44
CHRM4 P08173 1/20 0.44
CYP3A4 P08684 1/20 0.44
CHRM5 P08912 1/20 0.44
ADRA2A P08913 1/20 0.44
CYP2D6 P10635 1/20 0.44
CHRM1 P11229 1/20 0.44
TSHR P16473 1/20 0.44
ADRA2B P18089 1/20 0.44
ADRA2C P18825 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8131101 0.87 LMNA (0.53) DRD3DRD2LMNAJAK2HTT
SCHEMBL5729262 0.86 LMNA (0.52) DRD3DRD2LMNAJAK2HTT
Hydrochloric Acid SCHEMBL5728654 0.84 DRD3 (0.61) DRD3DRD2HTR1AHTR7MAOB
SCHEMBL83394 0.73 DRD3 (0.46) DRD3DRD2LMNAJAK2HTT
SCHEMBL10408884 0.73 SETD7 (0.66) DRD3DRD2LMNAHTTHTR1A
SCHEMBL3079984 0.73 DRD3 (0.51) DRD3DRD2LMNAJAK2HTT
SCHEMBL5728491 0.70 FNTA (0.50) DRD3DRD2LMNAHTTHTR1A
Hydrochloric Acid SCHEMBL5729405 0.70 LMNA (0.84) DRD3DRD2LMNAJAK2HTT
SCHEMBL3440240 0.70 MAOB (0.73) DRD2HTR1AHTR2AMAOBHTR6
SCHEMBL14028451 0.70 HTR1A (0.79) DRD3DRD2HTR1AMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1044197-B1 PIPERIDINYL-SUBSTITUTED PYRIDYLALKANE, ALKENE AND ALKYNE CARBOXAMIDES AS CYTOSTATIC AGENTS AND IMMUNOSUPPRESSANTS ASTELLAS PHARMA GMBH (DE) 2006-04-19 EP disclosed
US-6593344-B1 These substances have especially high cytostatic activities and pronounced immunosuppressive properties which make them suitable for therapeutic treatment in broad tumor spectrum and autoimmune diseases KLINGE PHARMA GMBH (DE) 2003-07-15 US disclosed